Extracts and Steroids from the Edible Mushroom Hypholoma lateritium Exhibit Anti-Inflammatory Properties by Inhibition of COX-2 and Activation of Nrf2
- Chem Biodivers. 2020 Sep;17(9):e2000391. doi: 10.1002/cbdv.202000391.
- 1. Department of Pharmacognosy, Interdisciplinary Excellence Center, University of Szeged, Eötvös u. 6., H-6720 Szeged, Hungary.
- 2. Department of Pharmacognosy, Semmelweis University, Üllői u. 26, H-1085, Budapest, Hungary.
- 3. Department of Pharmaceutical Botany, Faculty of Pharmacy, Jagiellonian, University Medical College, 9 Medyczna Street, 30-688, Kraków, Poland.
- 4. Department of Radioligands, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, 30-688, Kraków, Poland.
- 5. Interdisciplinary Center of Natural Products, University of Szeged, Eötvös u. 6., H-6720, Szeged, Hungary.
Hypholoma lateritium is an edible macrofungus with a common distribution in Europe, North America, and the Far East. The aim of this study was to investigate the potential anti-inflammatory effects of H. lateritium extracts and its isolated steroids: fasciculic acid B, fasciculol E, fasciculol C, lanosta-7,9(11)-diene-12β,21α-epoxy-2α,3β,24β,25-tetraol, fasciculol F, and demethylincisterol A2. Organic (hexane, chloroform and 50 % methanol) and water extracts of H. lateritium were subjected to in vitro assays to determine pro-inflammatory protein levels, such as cyclooxygenase-2 (COX-2), cytosolic prostaglandin E2 synthase (cPGES), and antioxidant nuclear factor (erythroid-derived 2)-like 2 (Nrf2). Fungal extracts demonstrated significant activities on pro-inflammatory protein levels with minor differences among the activities of the fractions of different polarities. All the compounds proved to exert notable inhibitory properties on COX-2 and were capable to stimulate the Nrf2 pathway. Fungal extracts and the compounds exerted no cytotoxic activities on RAW 264.7 cells.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: CalmodulinResearch Areas: Inflammation/Immunology
-
target: CalmodulinResearch Areas: Inflammation/Immunology